Brendan Smith
Stock Analyst at TD Cowen
(n/a)
# 4,406
Out of 4,416 analysts
3
Total ratings
n/a
Success rate
-26.85%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics | Initiates: Outperform | $54 | $39.91 | +35.30% | 1 | Feb 29, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $24.44 | - | 1 | Jul 21, 2023 | |
| DNLI Denali Therapeutics | Initiates: Outperform | n/a | $17.14 | - | 1 | Dec 5, 2022 |
Halozyme Therapeutics
Feb 29, 2024
Initiates: Outperform
Price Target: $54
Current: $39.91
Upside: +35.30%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $24.44
Upside: -
Denali Therapeutics
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $17.14
Upside: -